MetaADEDB 2.0 @ LMMD
montelukast
(UCHDWCPVSPXUMX-TZIWLTJVSA-N)
Structure
SMILES
OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1
Type(s)
Approved
ATC code(s)
R03DC03; R03DC53
Molecular Formula:
C35H36ClNO3S
Molecular Weight:
586.183
Log P:
8.9480
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
95.72
CAS Number(s):
142522-28-9; 158966-92-8
Synonym(s)
1.
montelukast
2.
MK 0476
3.
MK-0476
4.
Singulair
5.
montelukast sodium
6.
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
External Link(s)
MeSHC093875
PubChem Compound5281040
BindingDB50052024
ChEBI94710
50730
CHEMBLCHEMBL787
DrugBankDB00471
DrugCentral1836
IUPHAR/BPS Guide to PHARMACOLOGY3340
KEGGcpd:C07482
dr:D08229
Therapeutic Target DatabaseD00QET
ZINC3831151
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AnxietyFAERS: 732
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
2AngerFAERS: 424
Canada Vigilance: 2
Canada Vigilance
US FAERS
3Mood swingsFAERS: 379
Canada Vigilance: 3
Canada Vigilance
US FAERS
4CryingFAERS: 370
Canada Vigilance: 5
Canada Vigilance
US FAERS
5HeadacheFAERS: 306
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
6AgitationFAERS: 301
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
7Drug ineffectiveFAERS: 246
Canada Vigilance: 61
Canada Vigilance
OFFSIDES
US FAERS
8FatigueFAERS: 230
Canada Vigilance: 12
Canada Vigilance
OFFSIDES
SIDER
US FAERS
9Feeling abnormalFAERS: 208
Canada Vigilance: 6
Canada Vigilance
US FAERS
10Suicide attemptFAERS: 191
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
11Depressed moodFAERS: 182
Canada Vigilance: 3
Canada Vigilance
US FAERS
12ScreamingFAERS: 182
Canada Vigilance: 1
Canada Vigilance
US FAERS
13AsthmaFAERS: 177
Canada Vigilance: 16

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
14Product substitution issueFAERS: 172
Canada Vigilance: 5
Canada Vigilance
US FAERS
15Emotional disorderFAERS: 149US FAERS
16Completed SuicideFAERS: 138
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
17DizzinessFAERS: 134
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
18Personality ChangeFAERS: 132
Canada Vigilance: 3
Canada Vigilance
US FAERS
19MalaiseFAERS: 130
Canada Vigilance: 17
Canada Vigilance
US FAERS
20TremorFAERS: 128
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
21OverdoseFAERS: 117
Canada Vigilance: 2
Canada Vigilance
US FAERS
22Adverse eventFAERS: 116
Canada Vigilance: 2
Canada Vigilance
US FAERS
23NauseaFAERS: 115
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
24VomitingFAERS: 112
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
25RestlessnessFAERS: 100
Canada Vigilance: 2
Canada Vigilance
US FAERS
26SomnolenceFAERS: 93
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
27MyalgiaFAERS: 92
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
28ArthralgiaFAERS: 89
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
29PruritusFAERS: 89
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
30Abdominal PainFAERS: 87
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
31Educational problemFAERS: 86
Canada Vigilance: 1
Canada Vigilance
US FAERS
32UrticariaFAERS: 83
Canada Vigilance: 3
10982225CTD
SIDER
Canada Vigilance
US FAERS
33No adverse eventFAERS: 82US FAERS
34Product quality issueFAERS: 82OFFSIDES
US FAERS
35PainFAERS: 80
Canada Vigilance: 6
15935457CTD
SIDER
Canada Vigilance
US FAERS
36PalpitationsFAERS: 79
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
37Intentional self-injuryFAERS: 78
Canada Vigilance: 2
Canada Vigilance
US FAERS
38NervousnessFAERS: 74US FAERS
39AstheniaFAERS: 73
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
40Obsessive-Compulsive DisorderFAERS: 69US FAERS
41HypersensitivityFAERS: 64
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
42SomnambulismFAERS: 64
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
43ParanoiaFAERS: 57OFFSIDES
US FAERS
44Middle insomniaFAERS: 56OFFSIDES
US FAERS
45Drug exposure during pregnancyFAERS: 55US FAERS
46StressFAERS: 55
Canada Vigilance: 4
Canada Vigilance
US FAERS
47Physical assaultFAERS: 53US FAERS
48Chest discomfortFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
49EnuresisFAERS: 50SIDER
US FAERS
50WheezingFAERS: 50
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
51PneumoniaFAERS: 49
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
52Morbid thoughtsFAERS: 48US FAERS
53LethargyFAERS: 47
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
54EpilepsyFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
55AmnesiaFAERS: 45
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
56Drug dose omissionFAERS: 45US FAERS
57Poor quality sleepFAERS: 45US FAERS
58EpistaxisFAERS: 41
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
59SinusitisFAERS: 41
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
60Abdominal discomfortFAERS: 40
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
61Weight decreasedFAERS: 40
Canada Vigilance: 2
Canada Vigilance
US FAERS
62Oropharyngeal painFAERS: 39
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
63Chest PainFAERS: 38
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
64Memory impairmentFAERS: 37
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
65ConstipationFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
66Negative thoughtsFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
67FrustrationFAERS: 34US FAERS
68Initial insomniaFAERS: 34US FAERS
69ApathyFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Back PainFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
71SwellingFAERS: 33US FAERS
72ErythemaFAERS: 31
Canada Vigilance: 3
Canada Vigilance
US FAERS
73VasculitisFAERS: 30SIDER
US FAERS
74Excessive eye blinkingFAERS: 29US FAERS
75PallorFAERS: 29US FAERS
76Product use in unapproved indicationFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
77TinnitusFAERS: 29OFFSIDES
US FAERS
78DisorientationFAERS: 28SIDER
US FAERS
79Medication ErrorFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
80Oppositional Defiant DisorderFAERS: 28US FAERS
81DyspepsiaFAERS: 27
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
82EosinophiliaFAERS: 2710335014CTD
SIDER
US FAERS
83HostilityFAERS: 27SIDER
US FAERS
84Visual ImpairmentFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
85AlopeciaFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
86NegativismFAERS: 26US FAERS
87TachycardiaFAERS: 26
Canada Vigilance: 4
Canada Vigilance
US FAERS
88Activities of daily living impairedFAERS: 24OFFSIDES
US FAERS
89Conversion disorderFAERS: 24US FAERS
90Unevaluable eventFAERS: 24US FAERS
91SyncopeFAERS: 22US FAERS
92ChillsFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
93Impaired work abilityFAERS: 21US FAERS
94Prescribed overdoseFAERS: 21US FAERS
95School refusalFAERS: 21US FAERS
96Bipolar DisorderFAERS: 20US FAERS
97AnorexiaFAERS: 19US FAERS
98NasopharyngitisFAERS: 19
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
99Violence-related symptomFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
100DiscomfortFAERS: 18US FAERS
101Drug administration errorFAERS: 18US FAERS
102Eosinophilic granulomatosis with polyangiitisFAERS: 18
Canada Vigilance: 8
Canada Vigilance
US FAERS
103ThirstFAERS: 18
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
104AnhedoniaFAERS: 17US FAERS
105HypersomniaFAERS: 17US FAERS
106Obsessive thoughtsFAERS: 17US FAERS
107Product taste abnormalFAERS: 17US FAERS
108Accidental exposureFAERS: 16US FAERS
109DeafnessFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
110Drug dispensing errorFAERS: 16US FAERS
111Emotional distressFAERS: 16US FAERS
112InfluenzaFAERS: 16
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
113Myocardial InfarctionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
114AphasiaFAERS: 15US FAERS
115BronchitisFAERS: 15
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
116DysphoniaFAERS: 15US FAERS
117HypophagiaFAERS: 15US FAERS
118Inappropriate schedule of drug administrationFAERS: 15US FAERS
119Lip swellingFAERS: 15
Canada Vigilance: 3
Canada Vigilance
US FAERS
120Product use issueFAERS: 15US FAERS
121Psychiatric symptomFAERS: 15US FAERS
122Wrong technique in drug usage processFAERS: 15US FAERS
123nervous system disorderFAERS: 15SIDER
US FAERS
124Aspartate Aminotransferase IncreasedFAERS: 14SIDER
US FAERS
125Burning sensationFAERS: 14
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
126Drug prescribing errorFAERS: 14US FAERS
127Therapeutic response unexpected with drug substitutionFAERS: 14US FAERS
128ToothacheFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
129AngioedemaFAERS: 13
Canada Vigilance: 2
10982225CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
130BruxismFAERS: 13OFFSIDES
US FAERS
131DissociationFAERS: 13US FAERS
132DysgeusiaFAERS: 13OFFSIDES
US FAERS
133Eosinophilic PneumoniaFAERS: 13US FAERS
134InfectionFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
135PancreatitisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
136Throat irritationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
137ThrombocytopeniaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
138VertigoFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
139AbasiaFAERS: 12US FAERS
140Accidental overdoseFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
141Atrial FibrillationFAERS: 12US FAERS
142ChokingFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
143DysphemiaFAERS: 12US FAERS
144EczemaFAERS: 12SIDER
US FAERS
145HepatitisFAERS: 12SIDER
US FAERS
146HypotensionFAERS: 12US FAERS
147Joint swellingFAERS: 12US FAERS
148Pharmaceutical product complaintFAERS: 12US FAERS
149SneezingFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
150BronchospasmFAERS: 11US FAERS
151Cerebrovascular accidentFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
152Incorrect dose administeredFAERS: 11OFFSIDES
US FAERS
153LacerationFAERS: 11US FAERS
154Maternal exposure during pregnancyFAERS: 11US FAERS
155MetamorphopsiaFAERS: 11US FAERS
156Night sweatsFAERS: 11US FAERS
157Panic DisorderFAERS: 11US FAERS
158Sleep TalkingFAERS: 11OFFSIDES
US FAERS
159Alanine Aminotransferase IncreasedFAERS: 10SIDER
US FAERS
160Anaphylactic shockFAERS: 10SIDER
US FAERS
161Angina PectorisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
162Cold sweatFAERS: 10US FAERS
163Feeling jitteryFAERS: 10US FAERS
164FlatulenceFAERS: 10OFFSIDES
US FAERS
165Neck PainFAERS: 10US FAERS
166PurpuraFAERS: 10US FAERS
167Wrong technique in product usage processFAERS: 10US FAERS
168Acute psychosisFAERS: 9US FAERS
169AphoniaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
170ArthritisFAERS: 9
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
171Breast FeedingFAERS: 9US FAERS
172DermatitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
173Drug withdrawal syndromeFAERS: 9US FAERS
174Fight in schoolFAERS: 9US FAERS
175Sinus headacheFAERS: 9SIDER
US FAERS
176Urinary RetentionFAERS: 9US FAERS
177treatment failureFAERS: 9US FAERS
178BlindnessFAERS: 8US FAERS
179FormicationFAERS: 8OFFSIDES
US FAERS
180Hallucinations, mixedFAERS: 8US FAERS
181Head BangingFAERS: 8US FAERS
182MydriasisFAERS: 8US FAERS
183Pharyngolaryngeal PainFAERS: 8US FAERS
184Reaction to drug excipientsFAERS: 8US FAERS
185StaringFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
186ThrombosisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Unresponsive to stimuliFAERS: 8US FAERS
188Urinary IncontinenceFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
189Wrong product administeredFAERS: 8US FAERS
190AsphyxiaFAERS: 7US FAERS
191BelligerenceFAERS: 7US FAERS
192BlepharospasmFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
193Blood glucose decreasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
194BradycardiaFAERS: 7US FAERS
195CyanosisFAERS: 7US FAERS
196Depressed Level of ConsciousnessFAERS: 7US FAERS
197Diabetes MellitusFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
198Economic problemFAERS: 7US FAERS
199Feelings of worthlessnessFAERS: 7US FAERS
200Food AllergyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
201General physical health deteriorationFAERS: 7US FAERS
202HyperacusisFAERS: 7US FAERS
203ImpatienceFAERS: 7US FAERS
204Inappropriate affectFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
205Increased tendency to bruiseFAERS: 7US FAERS
206LymphadenopathyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
207Musculoskeletal PainFAERS: 7OFFSIDES
US FAERS
208Nasal PolypsFAERS: 7US FAERS
209Nerve injuryFAERS: 7US FAERS
210PetechiaeFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
211RhabdomyolysisFAERS: 7US FAERS
212ShockFAERS: 7US FAERS
213StomatitisFAERS: 7US FAERS
214Therapeutic response unexpectedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
215Abnormal sleep-related eventFAERS: 6US FAERS
216AgoraphobiaFAERS: 6US FAERS
217ArthropathyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
218CholelithiasisFAERS: 6US FAERS
219Dark circles under eyesFAERS: 6US FAERS
220Drug DependenceFAERS: 6US FAERS
221Drug administered to patient of inappropriate ageFAERS: 6US FAERS
222Ear discomfortFAERS: 6US FAERS
223Erythema MultiformeFAERS: 6OFFSIDES
SIDER
US FAERS
224Head discomfortFAERS: 6US FAERS
225IncontinenceFAERS: 6US FAERS
226Intercepted drug dispensing errorFAERS: 6US FAERS
227Leukocytoclastic vasculitisFAERS: 6SIDER
US FAERS
228Limb discomfortFAERS: 6US FAERS
229Mental status changesFAERS: 6US FAERS
230Nephrotic SyndromeFAERS: 6US FAERS
231Personality disorder of childhoodFAERS: 6US FAERS
232PharyngitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
233PoisoningFAERS: 6US FAERS
234Precocious PubertyFAERS: 6US FAERS
235PregnancyFAERS: 6US FAERS
236Product dispensing errorFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
237Respiratory FailureFAERS: 6US FAERS
238Status AsthmaticusFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
239TensionFAERS: 6US FAERS
240TheftFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
241AutophobiaFAERS: 5US FAERS
242Bone SarcomaFAERS: 5US FAERS
243Cardiac ArrestFAERS: 5US FAERS
244CellulitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
245Cerebral InfarctionFAERS: 5US FAERS
246Choking sensationFAERS: 5OFFSIDES
US FAERS
247Conduct DisorderFAERS: 5US FAERS
248DehydrationFAERS: 5US FAERS
249Diet refusalFAERS: 5US FAERS
250DysarthriaFAERS: 5US FAERS
251EcchymosisFAERS: 5US FAERS
252Flat affectFAERS: 5US FAERS
253FlushingFAERS: 5US FAERS
254Gastric ulcerFAERS: 5US FAERS
255HepatotoxicityFAERS: 5US FAERS
256HyperkinesiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
257HysterectomyFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
258Incorrect drug administration durationFAERS: 5US FAERS
259InflammationFAERS: 5
Canada Vigilance: 1
18059327
27702591
30276927
CTD
Canada Vigilance
US FAERS
260MenorrhagiaFAERS: 5US FAERS
261Mental impairmentFAERS: 5US FAERS
262Multiple allergiesFAERS: 5US FAERS
263MyopathyFAERS: 5US FAERS
264No adverse effectFAERS: 5US FAERS
265Otitis MediaFAERS: 5SIDER
US FAERS
266PolyneuropathyFAERS: 5US FAERS
267Product physical issueFAERS: 5US FAERS
268Productive CoughFAERS: 5US FAERS
269Pulmonary EmbolismFAERS: 5US FAERS
270Rash erythematousFAERS: 5US FAERS
271Respiratory distressFAERS: 5US FAERS
272Stevens-Johnson SyndromeFAERS: 525811541CTD
SIDER
US FAERS
273TachyphreniaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
274Visual disturbanceFAERS: 5US FAERS
275Alice in Wonderland SyndromeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
276Altered state of consciousnessFAERS: 4US FAERS
277Apparent deathFAERS: 4US FAERS
278Arthropod biteFAERS: 4US FAERS
279Back disorderFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
280Bipolar I disorderFAERS: 4US FAERS
281Blood alkaline phosphatase increasedFAERS: 4US FAERS
282Blood immunoglobulin E increasedFAERS: 4US FAERS
283Cerebral disorderFAERS: 4US FAERS
284CholestasisFAERS: 4US FAERS
285ChromaturiaFAERS: 4OFFSIDES
US FAERS
286Disease recurrenceFAERS: 4US FAERS
287DroolingFAERS: 4US FAERS
288Drug abuseFAERS: 4US FAERS
289Drug exposure via breast milkFAERS: 4US FAERS
290Drug ineffective for unapproved indicationFAERS: 4US FAERS
291Dysthymic DisorderFAERS: 4OFFSIDES
US FAERS
292Expired drug administeredFAERS: 4US FAERS
293Flight of ideasFAERS: 4US FAERS
294GastroenteritisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
295Growth retardationFAERS: 4US FAERS
296HungerFAERS: 4US FAERS
297HypospadiasFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
298IncoherentFAERS: 4US FAERS
299Incorrect product storageFAERS: 4US FAERS
300Mononeuropathy MultiplexFAERS: 4US FAERS
301Muscle tightnessFAERS: 4US FAERS
302Musculoskeletal chest painFAERS: 4US FAERS
303Musculoskeletal stiffnessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
304Nasal discomfortFAERS: 4US FAERS
305Performance status decreasedFAERS: 4US FAERS
306Peripheral swellingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
307Platelet dysfunctionFAERS: 4US FAERS
308PolydactylyFAERS: 4US FAERS
309Product packaging quantity issueFAERS: 4US FAERS
310Restless Legs SyndromeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
311Retinal Vein OcclusionFAERS: 4US FAERS
312RhinitisFAERS: 420332717CTD
SIDER
US FAERS
313SepsisFAERS: 4US FAERS
314Sjogren's SyndromeFAERS: 4US FAERS
315Skin lacerationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
316StrabismusFAERS: 4US FAERS
317Therapy cessationFAERS: 4US FAERS
318Upper-airway cough syndromeFAERS: 4US FAERS
319Accidental exposure to product by childFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
320AcneFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
321Acute sinusitisFAERS: 3OFFSIDES
US FAERS
322Adenoidal disorderFAERS: 3US FAERS
323AgeusiaFAERS: 3OFFSIDES
US FAERS
324Allergic reaction to excipientFAERS: 3US FAERS
325Analgesic asthma syndromeFAERS: 3US FAERS
326AnosmiaFAERS: 3US FAERS
327AspergillosisFAERS: 3US FAERS
328AtaxiaFAERS: 3US FAERS
329Atrial FlutterFAERS: 3US FAERS
330Blood glucose increasedFAERS: 3US FAERS
331Blood potassium decreasedFAERS: 3US FAERS
332Blood pressure fluctuationFAERS: 3US FAERS
333CandidiasisFAERS: 3US FAERS
334Cardiac FlutterFAERS: 3US FAERS
335CholecystitisFAERS: 3US FAERS
336Chronic sinusitisFAERS: 3OFFSIDES
US FAERS
337Complications of maternal exposure to therapeutic drugsFAERS: 3US FAERS
338Decreased immune responsivenessFAERS: 3US FAERS
339Depression suicidalFAERS: 3US FAERS
340DisabilityFAERS: 3US FAERS
341Drug effect incompleteFAERS: 3US FAERS
342Dry skinFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
343DysgraphiaFAERS: 3US FAERS
344Electrocardiogram abnormalFAERS: 3US FAERS
345Elevated moodFAERS: 3US FAERS
346Eosinophilic bronchitisFAERS: 3US FAERS
347Eosinophilic myocarditisFAERS: 3US FAERS
348ExcoriationFAERS: 3US FAERS
349Frustration tolerance decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
350Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
351Gastrointestinal PainFAERS: 3SIDER
US FAERS
352Gaze palsyFAERS: 3US FAERS
353General physical condition abnormalFAERS: 3US FAERS
354Growing painsFAERS: 3US FAERS
355HepatomegalyFAERS: 3US FAERS
356HerniaFAERS: 3US FAERS
357HyperphagiaFAERS: 3US FAERS
358HypertransaminasaemiaFAERS: 3US FAERS
359HyperventilationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
360Incorrect product formulation administeredFAERS: 3US FAERS
361Intentional misuseFAERS: 3US FAERS
362Intestinal ObstructionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
363Irritable Bowel SyndromeFAERS: 3US FAERS
364Joint sprainFAERS: 3OFFSIDES
US FAERS
365Joint stiffnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
366LaryngitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
367LeukopeniaFAERS: 3US FAERS
368Lower respiratory tract infectionFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
369Lupus-like syndromeFAERS: 3US FAERS
370LymphomaFAERS: 3US FAERS
371MalnutritionFAERS: 3US FAERS
372MenopauseFAERS: 3US FAERS
373NeuralgiaFAERS: 3US FAERS
374NystagmusFAERS: 3US FAERS
375Patent ductus arteriosusFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
376Peak expiratory flow rate abnormalFAERS: 3US FAERS
377Pericardial effusionFAERS: 3US FAERS
378PhotophobiaFAERS: 3US FAERS
379Physical abuseFAERS: 3US FAERS
380Post-Traumatic Stress DisorderFAERS: 3US FAERS
381Product dose omissionFAERS: 3
Canada Vigilance: 8
Canada Vigilance
US FAERS
382ProteinuriaFAERS: 3US FAERS
383PubertyFAERS: 3US FAERS
384Pulmonary FibrosisFAERS: 3
Canada Vigilance: 1
21381050CTD
Canada Vigilance
US FAERS
385Pulmonary congestionFAERS: 3US FAERS
386QuadriparesisFAERS: 3US FAERS
387Rectal ProlapseFAERS: 3US FAERS
388Renal cystFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
389Renal painFAERS: 3US FAERS
390RetchingFAERS: 3US FAERS
391ScabFAERS: 3US FAERS
392Scarlet FeverFAERS: 3US FAERS
393SciaticaFAERS: 3US FAERS
394Skin UlcerFAERS: 3US FAERS
395Skin necrosisFAERS: 3US FAERS
396Skin reactionFAERS: 3US FAERS
397Subcutaneous EmphysemaFAERS: 3OFFSIDES
US FAERS
398Tablet physical issueFAERS: 3US FAERS
399Therapy non-responderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
400TrichotillomaniaFAERS: 3US FAERS
401UlcerFAERS: 3US FAERS
402Urinary tract infectionFAERS: 3US FAERS
403jaundiceFAERS: 3SIDER
US FAERS
404AkathisiaFAERS: 2US FAERS
405Alcohol poisoningFAERS: 2US FAERS
406Anaphylactoid ReactionFAERS: 2US FAERS
407Ankle FractureFAERS: 2
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
408Aphthous StomatitisFAERS: 2OFFSIDES
US FAERS
409AtelectasisFAERS: 2US FAERS
410AuraFAERS: 2OFFSIDES
US FAERS
411Avulsion fractureFAERS: 2US FAERS
412BedriddenFAERS: 2US FAERS
413Bipolar II disorderFAERS: 2US FAERS
414Bladder dysfunctionFAERS: 2US FAERS
415Blood cholesterol increasedFAERS: 2US FAERS
416Blood glucose fluctuationFAERS: 2US FAERS
417Blood triglycerides increasedFAERS: 2US FAERS
418Blood urine presentFAERS: 2US FAERS
419Blunted affectFAERS: 2US FAERS
420Bone painFAERS: 2US FAERS
421Brain AbscessFAERS: 2US FAERS
422Breath HoldingFAERS: 2US FAERS
423Bronchial secretion retentionFAERS: 2US FAERS
424Carbon Monoxide PoisoningFAERS: 2US FAERS
425Cardiac discomfortFAERS: 2US FAERS
426Cardiac monitoringFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
427CardiomegalyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
428CatatoniaFAERS: 2US FAERS
429Cerebral arteritisFAERS: 2US FAERS
430Chronic respiratory failureFAERS: 2US FAERS
431Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
432ClaustrophobiaFAERS: 2US FAERS
433Clostridium difficile colitisFAERS: 2US FAERS
434ClubbingFAERS: 2US FAERS
435Coagulation test abnormalFAERS: 2US FAERS
436ColitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
437CoprolaliaFAERS: 2US FAERS
438Cor pulmonaleFAERS: 2US FAERS
439Coronary Artery DiseaseFAERS: 2US FAERS
440Coronary artery embolismFAERS: 2US FAERS
441Cytolytic hepatitisFAERS: 2US FAERS
442DeliriumFAERS: 2US FAERS
443DemyelinationFAERS: 2US FAERS
444Diffuse vasculitisFAERS: 2US FAERS
445Drug effective for unapproved indicationFAERS: 2US FAERS
446Duodenal UlcerFAERS: 2US FAERS
447Electroencephalogram abnormalFAERS: 2US FAERS
448Emergency CareFAERS: 2US FAERS
449Emotional povertyFAERS: 2US FAERS
450EpicondylitisFAERS: 2US FAERS
451EructationFAERS: 2US FAERS
452Erythema NodosumFAERS: 2SIDER
US FAERS
453Euphoric moodFAERS: 2OFFSIDES
US FAERS
454Eye irritationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
455Eye painFAERS: 2US FAERS
456Facial PainFAERS: 2US FAERS
457Facial ParesisFAERS: 2US FAERS
458Failure to ThriveFAERS: 2US FAERS
459FibromyalgiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
460Flank PainFAERS: 2US FAERS
461Foreign body in respiratory tractFAERS: 2US FAERS
462FractureFAERS: 2US FAERS
463Gastric pH decreasedFAERS: 2US FAERS
464GlossitisFAERS: 2US FAERS
465Guillain-Barre SyndromeFAERS: 2US FAERS
466Head titubationFAERS: 2US FAERS
467Heat ExhaustionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
468Hepatitis CFAERS: 2US FAERS
469HyperplasiaFAERS: 2US FAERS
470Hypertensive crisisFAERS: 2US FAERS
471HypoxiaFAERS: 2US FAERS
472Idiosyncratic drug reactionFAERS: 2US FAERS
473ImmunosuppressionFAERS: 2US FAERS
474Impaired driving abilityFAERS: 2OFFSIDES
US FAERS
475Incorrect route of drug administrationFAERS: 2US FAERS
476Infectious MononucleosisFAERS: 2US FAERS
477Injection site painFAERS: 2US FAERS
478Intentional product misuseFAERS: 2US FAERS
479Large intestine perforationFAERS: 2US FAERS
480Low density lipoprotein increasedFAERS: 2US FAERS
481MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
482Mass excisionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
483MeaslesFAERS: 2US FAERS
484Mental RetardationFAERS: 2US FAERS
485Migraine with AuraFAERS: 2US FAERS
486MonoplegiaFAERS: 2US FAERS
487Multiple drug overdose intentionalFAERS: 2OFFSIDES
US FAERS
488Muscle FatigueFAERS: 2US FAERS
489Muscle RigidityFAERS: 2US FAERS
490Muscular DystrophyFAERS: 2US FAERS
491MyopiaFAERS: 2SIDER
US FAERS
492NephrolithiasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
493Neuropsychiatric syndromeFAERS: 2US FAERS
494No reaction on previous exposure to drugFAERS: 2US FAERS
495Obsessive-compulsive symptomFAERS: 2US FAERS
496Oculomucocutaneous syndromeFAERS: 2US FAERS
497Open woundFAERS: 2US FAERS
498Oral painFAERS: 2US FAERS
499OverweightFAERS: 2US FAERS
500Paranasal sinus hypersecretionFAERS: 2US FAERS
501ParesisFAERS: 2US FAERS
502Partner stressFAERS: 2US FAERS
503PemphigusFAERS: 2US FAERS
504Peripheral embolismFAERS: 2US FAERS
505Pharyngeal swellingFAERS: 2US FAERS
506PhonophobiaFAERS: 2US FAERS
507PolyuriaFAERS: 2US FAERS
508Poor quality drug administeredFAERS: 2OFFSIDES
US FAERS
509Post procedural complicationFAERS: 2OFFSIDES
US FAERS
510Premenstrual syndromeFAERS: 2US FAERS
511PresyncopeFAERS: 2US FAERS
512Primary Biliary CholangitisFAERS: 2US FAERS
513Product formulation issueFAERS: 2US FAERS
514Psychomotor skills impairedFAERS: 2US FAERS
515Pulmonary EosinophiliaFAERS: 2SIDER
US FAERS
516Reaction to azo-dyesFAERS: 2US FAERS
517Reaction to preservativesFAERS: 2US FAERS
518Recalled product administeredFAERS: 2US FAERS
519Respiratory arrestFAERS: 2US FAERS
520Rheumatoid factor increasedFAERS: 2US FAERS
521Secretion dischargeFAERS: 2US FAERS
522Seizure like phenomenaFAERS: 2US FAERS
523Self-induced vomitingFAERS: 2US FAERS
524Sick Sinus SyndromeFAERS: 2US FAERS
525Skin hypoplasiaFAERS: 2US FAERS
526Skin lesionFAERS: 2US FAERS
527Skin noduleFAERS: 2US FAERS
528Sleep study abnormalFAERS: 2US FAERS
529SluggishnessFAERS: 2US FAERS
530Tardive DyskinesiaFAERS: 2OFFSIDES
US FAERS
531Testicular hypertrophyFAERS: 2US FAERS
532Therapeutic product effect decreasedFAERS: 2US FAERS
533Thermal burnFAERS: 2US FAERS
534ThyroiditisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
535Transaminases increasedFAERS: 2US FAERS
536Trigeminal NeuralgiaFAERS: 2US FAERS
537Tympanic Membrane PerforationFAERS: 2US FAERS
538UnemploymentFAERS: 2US FAERS
539VitiligoFAERS: 2US FAERS
540Vitreous floatersFAERS: 2US FAERS
541Vulvovaginal drynessFAERS: 2US FAERS
542Walking aid userFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
543White blood cell count decreasedFAERS: 2US FAERS
544X-ray limb abnormalFAERS: 2US FAERS
545Abdominal InfectionFAERS: 1US FAERS
546AbuliaFAERS: 1US FAERS
547AcarodermatitisFAERS: 1US FAERS
548Accidental drug intake by childFAERS: 1US FAERS
549Accidental exposure to product packagingFAERS: 1US FAERS
550Acute Coronary SyndromeFAERS: 1US FAERS
551AdenoiditisFAERS: 1US FAERS
552Allergy to chemicalsFAERS: 1US FAERS
553AllodyniaFAERS: 1US FAERS
554Alopecia AreataFAERS: 1US FAERS
555Alopecia totalisFAERS: 1US FAERS
556Alopecia universalisFAERS: 1US FAERS
557Altered visual depth perceptionFAERS: 1US FAERS
558AneurysmFAERS: 1US FAERS
559Anorexia NervosaFAERS: 1US FAERS
560Apparent life threatening eventFAERS: 1US FAERS
561Artificial crown procedureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
562AscitesFAERS: 1US FAERS
563AsthenopiaFAERS: 1US FAERS
564Asthma-Chronic Obstructive Pulmonary Disease Overlap SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
565AtopyFAERS: 1US FAERS
566Atypical pneumoniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
567Autoimmune thyroiditisFAERS: 1US FAERS
568BankruptcyFAERS: 1US FAERS
569Benign Rolandic EpilepsyFAERS: 1US FAERS
570Blood chromogranin A increasedFAERS: 1US FAERS
571Blood creatine phosphokinase increasedFAERS: 1US FAERS
572Blood creatinine increasedFAERS: 1US FAERS
573Blood immunoglobulin G increasedFAERS: 1US FAERS
574Blood pressure inadequately controlledFAERS: 1US FAERS
575Blood sodium decreasedFAERS: 1US FAERS
576Blood urea increasedFAERS: 1US FAERS
577Body temperature fluctuationFAERS: 1US FAERS
578Borderline Personality DisorderFAERS: 1US FAERS
579Brain ContusionFAERS: 1US FAERS
580BronchiolitisFAERS: 1US FAERS
581BronchopneumoniaFAERS: 1US FAERS
582CalciphylaxisFAERS: 1US FAERS
583Carpal Tunnel SyndromeFAERS: 1US FAERS
584CataplexyFAERS: 1US FAERS
585Cauda Equina SyndromeFAERS: 1US FAERS
586Cerebral cystFAERS: 1US FAERS
587Change in sustained attentionFAERS: 1US FAERS
588CheilitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
589Childhood depressionFAERS: 1US FAERS
590CholangitisFAERS: 1US FAERS
591Chronic Spontaneous UrticariaFAERS: 1US FAERS
592ClumsinessFAERS: 1US FAERS
593Cluster HeadacheFAERS: 1US FAERS
594Concomitant disease aggravatedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Congenital scoliosisFAERS: 1US FAERS
596Conjunctival cystFAERS: 1US FAERS
597ConjunctivitisFAERS: 1SIDER
US FAERS
598Cortisol decreasedFAERS: 1US FAERS
599CyanopsiaFAERS: 1US FAERS
600CystitisFAERS: 1US FAERS
601Death of relativeFAERS: 1US FAERS
602Decreased eye contactFAERS: 1US FAERS
603Deep Vein ThrombosisFAERS: 1US FAERS
604DementiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
605Dental cariesFAERS: 1US FAERS
606Device occlusionFAERS: 1US FAERS
607Diabetes InsipidusFAERS: 1US FAERS
608Diabetes mellitus inadequate controlFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
609Diabetic encephalopathyFAERS: 1US FAERS
610Disease ProgressionFAERS: 1US FAERS
611Dissociative disorderFAERS: 1US FAERS
612DiverticulumFAERS: 1OFFSIDES
US FAERS
613Double stranded DNA antibody positiveFAERS: 1US FAERS
614Drug effect variableFAERS: 1US FAERS
615Drug resistanceFAERS: 1US FAERS
616Drug screen false positiveFAERS: 1US FAERS
617Drug screen positiveFAERS: 1US FAERS
618Drug therapy changedFAERS: 1US FAERS
619Drug toxicityFAERS: 1US FAERS
620Drug withdrawal headacheFAERS: 1OFFSIDES
US FAERS
621DysmetropsiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
622DyspareuniaFAERS: 1US FAERS
623DysphasiaFAERS: 1US FAERS
624DystoniaFAERS: 1US FAERS
625DysuriaFAERS: 1US FAERS
626Ear congestionFAERS: 1US FAERS
627Echocardiogram abnormalFAERS: 1US FAERS
628Ejection Fraction DecreasedFAERS: 1US FAERS
629Electrocardiogram ST segment abnormalFAERS: 1US FAERS
630Electromechanical dissociationFAERS: 1US FAERS
631Endodontic procedureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
632Eosinophilic FasciitisFAERS: 1US FAERS
633Expired product administeredFAERS: 1US FAERS
634Exposure during breast feedingFAERS: 1US FAERS
635Exposure to toxic agentFAERS: 1US FAERS
636Extremity contractureFAERS: 1US FAERS
637Eye InfectionFAERS: 1US FAERS
638Eye inflammationFAERS: 1US FAERS
639Feeling ColdFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
640Foaming at mouthFAERS: 1OFFSIDES
US FAERS
641Food PoisoningFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
642Foreign body traumaFAERS: 1US FAERS
643Freezing phenomenonFAERS: 1US FAERS
644Full blood count decreasedFAERS: 1US FAERS
645Gait inabilityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
646Gastric DilatationFAERS: 1US FAERS
647Gastric infectionFAERS: 1US FAERS
648GastritisFAERS: 1US FAERS
649Gastrointestinal motility disorderFAERS: 1US FAERS
650GastroschisisFAERS: 1US FAERS
651General symptomFAERS: 1US FAERS
652Gluten sensitivityFAERS: 1US FAERS
653Heavy exposure to ultraviolet lightFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
654HemiplegiaFAERS: 1US FAERS
655Hepatic necrosisFAERS: 1US FAERS
656Hepatitis EFAERS: 1US FAERS
657HepatosplenomegalyFAERS: 1US FAERS
658Hip DysplasiaFAERS: 1US FAERS
659HistoplasmosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
660HomicideFAERS: 1US FAERS
661Hormone level abnormalFAERS: 1US FAERS
662House dust allergyFAERS: 1US FAERS
663HyperchlorhydriaFAERS: 1US FAERS
664HyperkeratosisFAERS: 1OFFSIDES
US FAERS
665Hypertensive heart diseaseFAERS: 1US FAERS
666HypogeusiaFAERS: 1US FAERS
667HypopituitarismFAERS: 1US FAERS
668Hypothalamo-pituitary disorderFAERS: 1US FAERS
669ImmobileFAERS: 1US FAERS
670Immune thrombocytopenic purpuraFAERS: 1US FAERS
671Impaired gastric emptyingFAERS: 1OFFSIDES
US FAERS
672Impaired reasoningFAERS: 1US FAERS
673Implant site painFAERS: 1US FAERS
674Implant site reactionFAERS: 1US FAERS
675Inability to crawlFAERS: 1US FAERS
676Inappropriate schedule of product administrationFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
677Incorrect storage of drugFAERS: 1US FAERS
678Infectious peritonitisFAERS: 1US FAERS
679Intercepted drug prescribing errorFAERS: 1US FAERS
680Intrusive thoughtsFAERS: 1US FAERS
681Jugular vein distensionFAERS: 1US FAERS
682Juvenile arthritisFAERS: 1US FAERS
683Lactation DisorderFAERS: 1US FAERS
684Lactose IntoleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
685LagophthalmosFAERS: 1US FAERS
686LaryngospasmFAERS: 1US FAERS
687Laser TherapyFAERS: 1US FAERS
688LazinessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
689LeukocytosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
690Lichen PlanusFAERS: 1US FAERS
691Limb injuryFAERS: 1US FAERS
692Limbic EncephalitisFAERS: 1US FAERS
693Loss of personal independence in daily activitiesFAERS: 1US FAERS
694Lyme DiseaseFAERS: 1US FAERS
695Magnesium DeficiencyFAERS: 1US FAERS
696Manufacturing production issueFAERS: 1US FAERS
697Mastication disorderFAERS: 1US FAERS
698Maternal exposure before pregnancyFAERS: 1US FAERS
699Mechanical urticariaFAERS: 1US FAERS
700Medical device complicationFAERS: 1US FAERS
701MeningitisFAERS: 1US FAERS
702MetrorrhagiaFAERS: 1US FAERS
703Milk AllergyFAERS: 1US FAERS
704Mouth swellingFAERS: 1US FAERS
705Multiple SclerosisFAERS: 1US FAERS
706Muscle SpasticityFAERS: 1US FAERS
707Muscle enzyme increasedFAERS: 1US FAERS
708MyocarditisFAERS: 1US FAERS
709MyositisFAERS: 1US FAERS
710Nasal pruritusFAERS: 1US FAERS
711Nerve DegenerationFAERS: 130222980CTD
US FAERS
712Neuropsychological test abnormalFAERS: 1US FAERS
713NeutropeniaFAERS: 1US FAERS
714No adverse drug reactionFAERS: 1US FAERS
715NoduleFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
716Non-cardiac chest painFAERS: 1OFFSIDES
US FAERS
717Ocular discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
718Ocular icterusFAERS: 1US FAERS
719OliguriaFAERS: 1US FAERS
720Optic NeuritisFAERS: 1US FAERS
721Oral pruritusFAERS: 1US FAERS
722Oromandibular dystoniaFAERS: 1US FAERS
723Oropharyngeal discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
724OsteopeniaFAERS: 1OFFSIDES
US FAERS
725OsteoporosisFAERS: 1US FAERS
726Oxygen consumption decreasedFAERS: 1US FAERS
727Oxygen saturation abnormalFAERS: 1US FAERS
728Packaging design issueFAERS: 1US FAERS
729Pain of skinFAERS: 1US FAERS
730Palliative CareFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
731Palmar erythemaFAERS: 1US FAERS
732Paranoid Personality DisorderFAERS: 1US FAERS
733ParapsoriasisFAERS: 1US FAERS
734ParasomniaFAERS: 1US FAERS
735Patient IsolationFAERS: 1US FAERS
736PericarditisFAERS: 1US FAERS
737PeriodontitisFAERS: 1US FAERS
738Perioral DermatitisFAERS: 1US FAERS
739PeritonitisFAERS: 1US FAERS
740PertussisFAERS: 1US FAERS
741PneumothoraxFAERS: 1OFFSIDES
US FAERS
742Polyglandular disorderFAERS: 1US FAERS
743PolyhydramniosFAERS: 1US FAERS
744PolyserositisFAERS: 1US FAERS
745Procedural complicationFAERS: 1US FAERS
746Product availability issueFAERS: 1US FAERS
747Product closure issueFAERS: 1US FAERS
748Product comminglingFAERS: 1US FAERS
749Product complaintFAERS: 1US FAERS
750Product contamination chemicalFAERS: 1US FAERS
751Product contamination physicalFAERS: 1US FAERS
752Product design confusionFAERS: 1US FAERS
753Product distribution issueFAERS: 1US FAERS
754Product label issueFAERS: 1US FAERS
755Product packaging issueFAERS: 1US FAERS
756Product prescribing issueFAERS: 1US FAERS
757Product quality control issueFAERS: 1US FAERS
758Product shape issueFAERS: 1US FAERS
759Product size issueFAERS: 1US FAERS
760Product solubility abnormalFAERS: 1US FAERS
761Protein urine presentFAERS: 1US FAERS
762Pulmonary HypertensionFAERS: 1US FAERS
763Pulmonary malformationFAERS: 1US FAERS
764Pulmonary thrombosisFAERS: 1US FAERS
765Pulmonary vasculitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
766Purulent dischargeFAERS: 1US FAERS
767Reaction to excipientFAERS: 1US FAERS
768Reaction to food additiveFAERS: 1US FAERS
769Rebound effectFAERS: 1US FAERS
770Refusal of treatment by relativeFAERS: 1US FAERS
771Relapsing FeverFAERS: 1US FAERS
772Respiratory DepressionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
773Ruptured cerebral aneurysmFAERS: 1US FAERS
774SarcoidosisFAERS: 1US FAERS
775SchizophreniaFAERS: 1OFFSIDES
US FAERS
776Seasonal Affective DisorderFAERS: 1US FAERS
777Secondary ticFAERS: 1US FAERS
778Selective eating disorderFAERS: 1US FAERS
779Sensory level abnormalFAERS: 1US FAERS
780Separation Anxiety DisorderFAERS: 1US FAERS
781Septic ShockFAERS: 1US FAERS
782Seronegative arthritisFAERS: 1US FAERS
783Serum SicknessFAERS: 1US FAERS
784Serum serotonin decreasedFAERS: 1US FAERS
785Shoulder PainFAERS: 1US FAERS
786Simple Partial SeizuresFAERS: 1US FAERS
787Single umbilical arteryFAERS: 1US FAERS
788Sinoatrial BlockFAERS: 1US FAERS
789Skin PapillomaFAERS: 1US FAERS
790Skin tightnessFAERS: 1US FAERS
791Sleep ParalysisFAERS: 1US FAERS
792SnoringFAERS: 1US FAERS
793SoporFAERS: 1US FAERS
794Spinal column injuryFAERS: 1US FAERS
795SplenomegalyFAERS: 1US FAERS
796Status EpilepticusFAERS: 1US FAERS
797StubbornnessFAERS: 1US FAERS
798Swelling of eyelidFAERS: 1US FAERS
799SynovitisFAERS: 1US FAERS
800TalipesFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
801Therapeutic response changedFAERS: 1US FAERS
802Therapy changeFAERS: 1US FAERS
803Thrombocytopenic purpuraFAERS: 1US FAERS
804ThrombophlebitisFAERS: 1US FAERS
805Thrombotic strokeFAERS: 1US FAERS
806Thyroid NeoplasmFAERS: 1US FAERS
807Tongue bitingFAERS: 1US FAERS
808Tongue movement disturbanceFAERS: 1US FAERS
809Tooth ExtractionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
810Toxic Epidermal NecrolysisFAERS: 1SIDER
US FAERS
811Toxicity to various agentsFAERS: 1US FAERS
812Transmission of drug via semenFAERS: 1US FAERS
813Trisomy 21FAERS: 1US FAERS
814TuberculosisFAERS: 1US FAERS
815UnderweightFAERS: 1US FAERS
816Urge IncontinenceFAERS: 1US FAERS
817Uterine CancerFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
818Vaccination failureFAERS: 1US FAERS
819Vanishing bile duct syndromeFAERS: 1US FAERS
820Vascular ruptureFAERS: 1US FAERS
821Vasodilation procedureFAERS: 1US FAERS
822Ventricular FibrillationFAERS: 1US FAERS
823Ventricular arrhythmiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
824Viral sinusitisFAERS: 1US FAERS
825Viral upper respiratory tract infectionFAERS: 1US FAERS
826Visceral congestionFAERS: 1US FAERS
827Vocal Cord ParalysisFAERS: 1US FAERS
828Vulvovaginal mycotic infectionFAERS: 1US FAERS
829Wheelchair userFAERS: 1US FAERS
830White blood cell count abnormalFAERS: 1US FAERS
831Abdominal massOFFSIDES
832Abnormal visionOFFSIDES
833AbscessOFFSIDES
834AbuseOFFSIDES
835AcanthosisOFFSIDES
836Acid refluxOFFSIDES
837Acute bronchitisSIDER
838Acute kidney injuryCanada Vigilance: 128902463CTD
Canada Vigilance
839Acute respiratory failureOFFSIDES
840AdenitisOFFSIDES
841Adnexa uteri painOFFSIDES
842Adrenal massOFFSIDES
843AkinesiaOFFSIDES
844Anal FistulaOFFSIDES
845Animal biteOFFSIDES
846Application site erythemaOFFSIDES
847Application site irritationOFFSIDES
848Application site painOFFSIDES
849Application site pruritusOFFSIDES
850Application site scarOFFSIDES
851Application site urticariaOFFSIDES
852Application site vesiclesOFFSIDES
853Asthma, Aspirin-Induced17924829
19667532
CTD
854Asthma, Exercise-Induced10984370
19667531
CTD
855Benign NeoplasmOFFSIDES
856Benign neoplasm of spinal cordOFFSIDES
857Biliary dilatationOFFSIDES
858Bleeding tendencySIDER
859Blood GlucoseOFFSIDES
860Blood and lymphatic system disordersSIDER
861Blood immunoglobulin G decreasedOFFSIDES
862Blood triglyceridesOFFSIDES
863Blurred visionOFFSIDES
864Bowel movement irregularityOFFSIDES
865Bowen's DiseaseOFFSIDES
866Breast MicrocalcificationOFFSIDES
867BursitisOFFSIDES
868Carotid artery occlusionOFFSIDES
869Catheter related infectionOFFSIDES
870Cervix carcinomaCanada Vigilance: 1Canada Vigilance
871Chemical and Drug Induced Liver Injury15069001
30276927
CTD
872Chronic Fatigue SyndromeOFFSIDES
873Chronic Obstructive Airway DiseaseOFFSIDES
874CirrhosisOFFSIDES
875Cognition Disorders27702591CTD
876Compression fractureOFFSIDES
877Congenital tricuspid valve incompetenceOFFSIDES
878Cystic FibrosisCanada Vigilance: 1Canada Vigilance
879CystCanada Vigilance: 1Canada Vigilance
880Delusional perceptionOFFSIDES
881Dental FistulaCanada Vigilance: 1Canada Vigilance
882Dental discomfortOFFSIDES
883DependenceOFFSIDES
884Dependent Personality DisorderOFFSIDES
885Device FailureOFFSIDES
886Device related infectionOFFSIDES
887DiabetesOFFSIDES
888DiarrheaOFFSIDES
889DiverticulitisOFFSIDES
890DrowsinessOFFSIDES
SIDER
891Drug delivery system malfunctionOFFSIDES
892Encephalomalacia30222980CTD
893Ethmoid sinus surgeryOFFSIDES
894Fat redistributionOFFSIDES
895Febrile NeutropeniaOFFSIDES
896Fractures, Closed19544365CTD
897GangreneOFFSIDES
898GastrectomyCanada Vigilance: 1Canada Vigilance
899Gastrointestinal carcinomaCanada Vigilance: 1Canada Vigilance
900GingivitisCanada Vigilance: 1Canada Vigilance
901Glaucoma surgeryCanada Vigilance: 1Canada Vigilance
902GlaucomaCanada Vigilance: 1Canada Vigilance
903Gliosis30222980CTD
904GoutCanada Vigilance: 1Canada Vigilance
905Grip strength decreasedCanada Vigilance: 1Canada Vigilance
906Hepatic infiltration eosinophilicSIDER
907HydrocephalusOFFSIDES
908Infective exacerbation of chronic obstructive airways diseaseOFFSIDES
909InfestationSIDER
910Infusion site mobility decreasedOFFSIDES
911Injection site dermatitisOFFSIDES
912Injection site infectionOFFSIDES
913Injection site irritationOFFSIDES
914Intentional drug misuseOFFSIDES
915Intervertebral Disc DegenerationCanada Vigilance: 1Canada Vigilance
OFFSIDES
916Intervertebral disc disorderOFFSIDES
917Joint Range of Motion DecreasedOFFSIDES
918Joint injuryOFFSIDES
919Livedo ReticularisOFFSIDES
920Loose toothOFFSIDES
921Low birth weight babyCanada Vigilance: 1Canada Vigilance
922LymphedemaOFFSIDES
923MastectomyCanada Vigilance: 1Canada Vigilance
OFFSIDES
924Medication residueOFFSIDES
925Meniscus injuryCanada Vigilance: 1Canada Vigilance
926Migraine Disorders10759916CTD
927Mitral Valve StenosisOFFSIDES
928Mitral valve sclerosisOFFSIDES
929MoaningOFFSIDES
930MononeuritisOFFSIDES
931Multiple sclerosis relapseOFFSIDES
932Muscle WeaknessOFFSIDES
933Muscle strainCanada Vigilance: 1Canada Vigilance
934Musculoskeletal discomfortSIDER
935MyelitisOFFSIDES
936NeuropathySIDER
937OnychoclasisOFFSIDES
938Optic NeuropathyOFFSIDES
939Oral candidiasisCanada Vigilance: 2Canada Vigilance
940Oral infectionOFFSIDES
941Oral torusOFFSIDES
942OsteomyelitisOFFSIDES
943OsteoradionecrosisOFFSIDES
944Patellofemoral Pain SyndromeOFFSIDES
945Pathogen resistanceOFFSIDES
946PolymyositisOFFSIDES
947Polysubstance dependenceOFFSIDES
948PostmenopauseOFFSIDES
949Postoperative Complications15925911CTD
950PouchitisOFFSIDES
951Pulmonary arterial hypertensionOFFSIDES
952Pulmonary painCanada Vigilance: 1Canada Vigilance
953PyuriaSIDER
954Respiratory tract congestionCanada Vigilance: 2Canada Vigilance
955RetrocollisOFFSIDES
956RhinorrheaOFFSIDES
957SerositisOFFSIDES
958Sinus antrostomyOFFSIDES
959Sinus operationCanada Vigilance: 1Canada Vigilance
960Skeletal injuryOFFSIDES
961Skin irritationCanada Vigilance: 1Canada Vigilance
962Sleep Apnea, Obstructive19118273CTD
963Spinal Cord Injuries18059327CTD
964Splenic InfarctionOFFSIDES
965Substance Withdrawal Syndrome18840427CTD
966SuicideSIDER
967SunburnCanada Vigilance: 1Canada Vigilance
968Temper tantrumSIDER
969TendinitisOFFSIDES
970Thrombosis in deviceOFFSIDES
971TonsillitisSIDER
972Tooth InfectionCanada Vigilance: 1Canada Vigilance
SIDER
973TracheobronchitisSIDER
974Traumatic liver injurySIDER
975TraumaSIDER
976Uterine PolypOFFSIDES
977Vaginal lesionOFFSIDES
978Vasculitic rashSIDER
979Venous InsufficiencyOFFSIDES
980Vitamin B 12 DeficiencyOFFSIDES
981Weight GainOFFSIDES
982XerosisOFFSIDES
983effusionOFFSIDES
984muscle injuryOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.